Innoviva (INVA) Times Interest Earned (2010 - 2026)
Innoviva's (INVA) quarterly Times Interest Earned came in at $1.43 in Q1 2026, down 8.94% YoY from $1.58 in Q1 2025, and up 133.92% on a QoQ basis from -$4.23 in Q4 2025.
Innoviva (INVA) Times Interest Earned (2010 - 2026) Analysis & Trends
Innoviva (INVA) has 17 years of Times Interest Earned data on file, last reported at $1.43 in Q1 2026.
- Quarterly Times Interest Earned fell 8.94% year-over-year to $1.43 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.44 (down 6.54% YoY) and the FY2025 annual result came in at $3.33, up 274.24% from the prior year.
- Times Interest Earned grew to $1.43 in Q1 2026, from -$4.23 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $9.94 in Q3 2023 to a low of -$6.58 in Q2 2022.
- A 5-year average of $1.11 and a median of -$0.06 in 2024 frame the typical range for Times Interest Earned.
- The widest YoY moves for Times Interest Earned: up 341.82% in 2025, down 7428.39% in 2025.
- Tracing INVA's Times Interest Earned over 5 years: stood at -$1.85 in 2022, then increased by 1.37% to -$1.83 in 2023, then jumped by 96.93% to -$0.06 in 2024, then slumped by 7428.39% to -$4.23 in 2025, then surged by 133.92% to $1.43 in 2026.
- The last three Times Interest Earned figures came in at $1.43 (Q1 2026), -$4.23 (Q4 2025), and $9.32 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Innoviva | 1.54 Bn | 968.79 Mn | 90.62 Mn | 1.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.91 |
| Mar 31, 2026 | 1.43 |
| Dec 31, 2025 | -4.23 |
| Sep 30, 2025 | 9.32 |
| Jun 30, 2025 | 1.85 |
| Mar 31, 2025 | 1.58 |
| Dec 31, 2024 | -0.06 |
| Sep 30, 2024 | 7.09 |
| Jun 30, 2024 | 2.12 |
| Mar 31, 2024 | -0.65 |
| Dec 31, 2023 | -1.83 |
| Sep 30, 2023 | 9.94 |
| Jun 30, 2023 | -1.21 |
| Mar 31, 2023 | -1.41 |
| Dec 31, 2022 | -1.85 |
| Sep 30, 2022 | 6.10 |
| Jun 30, 2022 | -6.58 |
| Mar 31, 2022 | -2.74 |
| Dec 31, 2021 | -0.16 |
| Sep 30, 2021 | 19.02 |